Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient

US Patent 9468598 · Granted Oct 18, 2016

Estimated economic value: $39,047,000

Assignee

Inventors

View full patent text on Google Patents →